AstraZeneca taps Biggest Loser host Bob Harper for heart attack survivors push

Bob Harper fitness guru
AstraZeneca has enlisted fitness coach, author and heart attack survivor Bob Harper in a new campaign for survivors.

Bob Harper knows the ins and outs of being a survivor firsthand: The Biggest Loser coach and fitness guru suffered an unexpected and near-fatal heart attack in February. Now, Harper has teamed with AstraZeneca to raise awareness and create community for survivors in a campaign that asks people to write personal essays telling their stories.

Called “Survivors Have Heart,” the online effort will take submissions of 500-word-or-less essays from heart attack survivors from the last three years. Five stories will be chosen, and the winners will be given a trip to New York, where they will meet with Harper and be inducted as the first members of the Survivors Club, a heart attack survivor’s network. The goal of the campaign is to let heart attack survivors know they don’t have to go it alone on the complex journey after an attack.

RELATED: AstraZeneca executives try to shift I-O focus with China, Brilinta wins

Whitepaper

Developing COVID-19 vaccines may not be enough: Turning vaccines into vaccinations

COVID-19 vaccines are being developed at a breakneck pace, but a broken supply chain could derail that momentum. What are the steps needed to help ensure the medical supply chain is up to the task?

AstraZeneca reached out to Harper after hearing his survivor story to partner on an effort and discovered that he'd been prescribed the company's own clot-fighting drug Brilinta as part of his recovery plan.

“Our mission with Survivors Have Heart is that these stories are heard and that patients can feel a connection to one another’s journey to enable them to continue to play an active role to reduce the risk of having another heart attack,” said Kiersten Combs, AstraZeneca executive director, cardiovascular, in an email interview.

Harper, as spokesman, will appear on behalf of the campaign in communications and promotional channels including traditional and online media, she said.

RELATED: Can AstraZeneca afford its fervent commitment to paying a high dividend?

Harper said in a news release, “Being a heart attack survivor adds you to a club you never want to join, but once you are a part of it, you feel bonded by the experience. As survivors, we carry each other and together, with the support of networks like Survivors Have Heart, we can make a meaningful difference in raising awareness on how to navigate this complex journey.”

AstraZeneca is also running a Brilinta DTC TV ad campaign in the spring featuring real heart attack survivors. Sales of the drug are on the upswing; in the first half of this year, Brilinta pulled in almost $500 million in sales, up 28% over last year. New scripts in the U.S. also grew more than a third.

Suggested Articles

With tens of millions of Americans tuned into Tuesday’s presidential debate, the race for a COVID-19 vaccine took center stage in a big way.

A $300M pandemic ad campaign may be falling apart as HHS employees push back, celebrities balk and agency brass push a rushed timeline, Politico says.

With a pack of drugmakers angling for COVID-19 vaccine approvals in the coming months, the task of global distribution is more important than ever. Wi